Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Carlos S, Mosteiro"'
Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
Autor:
Tania Cid‐Díaz, Saúl Leal‐López, Fátima Fernández‐Barreiro, Jessica González‐Sánchez, Icía Santos‐Zas, Luis J. Andrade‐Bulos, Manuel E. Rodríguez‐Fuentes, Carlos S. Mosteiro, Vincent Mouly, Xesús Casabiell, Jose Luis Relova, Yolanda Pazos, Jesus P. Camiña
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 493-505 (2021)
Abstract Background A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic processes and how t
Externí odkaz:
https://doaj.org/article/6aba5e89c5064f319ade19594e974fcf
Autor:
Jessica González‐Sánchez, Agustín Sánchez‐Temprano, Tania Cid‐Díaz, Regina Pabst‐Fernández, Carlos S. Mosteiro, Rosalía Gallego, Ruben Nogueiras, Xesús Casabiell, Gillian S. Butler‐Browne, Vincent Mouly, José Luis Relova, Yolanda Pazos, Jesús P. Camiña
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 9, Iss 6, Pp 1063-1078 (2018)
Abstract Background This study was performed to test the therapeutic potential of obestatin, an autocrine anabolic factor regulating skeletal muscle repair, to ameliorate the Duchenne muscular dystrophy (DMD) phenotype. Methods and results Using a mu
Externí odkaz:
https://doaj.org/article/ac85ac9944404db6b8a8d3a098d48356
Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
Autor:
Vincent Mouly, José Luis Relova, Saul Leal-lopez, Jesus P. Camiña, Manuel E. Rodríguez‐Fuentes, Icía Santos-Zas, Luis J. Andrade‐Bulos, Jessica González-Sánchez, Yolanda Pazos, Carlos S. Mosteiro, Xesús Casabiell, Tania Cid-Díaz, Fátima Fernández‐Barreiro
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 493-505 (2021)
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2021, 12 (2), pp.493-505. ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2021, 12 (2), pp.493-505. ⟨10.1002/jcsm.12677⟩
International audience; Background: A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3ea29729724ef9bd54613290241f11
https://doaj.org/article/6aba5e89c5064f319ade19594e974fcf
https://doaj.org/article/6aba5e89c5064f319ade19594e974fcf
Autor:
Maria Amil, Andrea G. Izquierdo, Alfredo Fernández-Quintela, Felipe F. Casanueva, Carlos S. Mosteiro, María P. Portillo, Marcos C. Carreira, Ana B. Crujeiras, Tomás García-Caballero
Publikováno v:
The FASEB Journal. 34:2312-2325
The epidemiological evidence regarding the association of obesity with liver disease and possibly hepatocellular carcinoma highlights the need for investigations of whether obesity itself could induce the differential expression of genes commonly ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58436843e787f5975b0f59840996b5bc
https://doi.org/10.1096/fj.201901147rr
https://doi.org/10.1096/fj.201901147rr
Autor:
Saul Leal-lopez, Agustin Sanchez-Temprano, Rosalia Gallego, Carlos S. Mosteiro, Jessica González-Sánchez, Jesus P. Camiña, Yolanda Pazos, Jose L. Relova
Background. Injuries to the peripheral nerve system are common conditions, with broad spectrum of symptoms depending on the impaired nerves and severity of damage. Although peripheral nervous system retains a remarkable ability for regeneration, it i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b971f927936e65701858a685665eb46c
https://doi.org/10.21203/rs.3.rs-55898/v1
https://doi.org/10.21203/rs.3.rs-55898/v1
Autor:
Begoña O Alén, Lidia Nieto, Uxía Gurriarán-Rodríguez, Carlos S Mosteiro, Juan C Álvarez-Pérez, María Otero-Alén, Jesús P Camiña, Rosalía Gallego, Tomás García-Caballero, Manuel Martín-Pastor, Felipe F Casanueva, Jesús Jiménez-Barbero, Yolanda Pazos
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e45434 (2012)
The quest for therapeutic applications of obestatin involves, as a first step, the determination of its 3D solution structure and the relationship between this structure and the biological activity of obestatin. On this basis, we have employed a comb
Externí odkaz:
https://doaj.org/article/403c93e7081f43d182c74153a8938659
Autor:
José Luis Relova, Xesús Casabiell, Jesus P. Camiña, Carlos S. Mosteiro, Jessica González-Sánchez, Gillian Butler-Browne, Yolanda Pazos, Rosalía Gallego, Tania Cid-Díaz, Rubén Nogueiras, Agustin Sanchez-Temprano, Vincent Mouly, Regina Pabst‐Fernández
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle. 9:1063-1078
BACKGROUND This study was performed to test the therapeutic potential of obestatin, an autocrine anabolic factor regulating skeletal muscle repair, to ameliorate the Duchenne muscular dystrophy (DMD) phenotype. METHODS AND RESULTS Using a multidiscip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ea7e5408774589453e9318215455706
https://doi.org/10.1002/jcsm.12338
https://doi.org/10.1002/jcsm.12338
Autor:
Tomás García-Caballero, Yolanda Pazos, Carlos S. Mosteiro, Icía Santos-Zas, Uxía Gurriarán-Rodríguez, Jessica González-Sánchez, Tania Cid-Díaz, Jesus P. Camiña, Xesús Casabiell, Vincent Mouly
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle. 8:974-990
Background: Many pathological states characterized by muscle atrophy are associated with an increase in circulating glucocorticoids and poor patient prognosis, making it an important target for treatment. The development of treatments for glucocortic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2db2279f82ed1f78ad721b08eb56b74
https://doi.org/10.1002/jcsm.12222
https://doi.org/10.1002/jcsm.12222
Autor:
Victoria García-Castro, Carlos S. Mosteiro, María Otero Alén, Andrés Beiras, Saul Leal-lopez, Yolanda Pazos, Begoña O. Alén, Tomás García-Caballero, Jesus P. Camiña, Rosalía Gallego, Patricia Viaño, Felipe F. Casanueva
Publikováno v:
Oncotarget
// Begona O. Alen 1, 2 , Saul Leal-Lopez 1, 2 , Maria Otero Alen 3, 4 , Patricia Viano 3, 4 , Victoria Garcia-Castro 4 , Carlos S. Mosteiro 1, 2 , Andres Beiras 3, 4, 5 , Felipe F. Casanueva 1, 2, 6 , Rosalia Gallego 2, 3, 5 , Tomas Garcia-Caballero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d04208eb60cfd0d7f3a4d4deafdc022e
https://doi.org/10.18632/oncotarget.6718
https://doi.org/10.18632/oncotarget.6718
Autor:
Carlos S. Mosteiro, Tania Cid-Díaz, Rosalía Gallego, Yolanda Pazos, Monica Bouzo-Lorenzo, Xesús Casabiell, Icía Santos-Zas, Vincent Mouly, José Señarís, Felipe F. Casanueva, Uxía Gurriarán-Rodríguez, Jesus P. Camiña, Gabriela Figueroa, Jessica González-Sánchez
Publikováno v:
Cellular and Molecular Life Sciences. 73:617-635
Obestatin/GPR39 signaling stimulates skeletal muscle repair by inducing the expansion of satellite stem cells as well as myofiber hypertrophy. Here, we describe that the obestatin/GPR39 system acts as autocrine/paracrine factor on human myogenesis. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354467b645ecf57c04772737df22d166
https://doi.org/10.1007/s00018-015-1994-z
https://doi.org/10.1007/s00018-015-1994-z